Literature DB >> 3192267

Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.

E Wiener1, V M Jolliffe, H C Scott, B M Kumpel, K M Thompson, M D Melamed, N C Hughes-Jones.   

Abstract

Seven IgG1 and seven IgG3 human monoclonal antibodies derived from heterohybridoma or Epstein-Barr virus-transformed lymphocytes and specific for the D antigen of the human Rh blood group system were tested for their ability to bring about red cell attachment to and phagocytosis by monocytes. The antibodies produced by the heterohybridomas were also investigated for their potency to mediate antibody-dependent cellular cytotoxicity (ADCC) by monocytes. When red cells were sensitized with any of the IgG1 anti-D antibodies, most of them were ingested by the phagocytes. By contrast, many of the red cells coated with any of the IgG3 antibodies remained attached to the monocyte surface while only few underwent phagocytosis. Some of the attached red cells remained on the phagocyte exterior for a considerable length of time. The ADCC activities of the IgG3 anti-D antibodies was greater than that of the IgG1 anti-D antibodies. The results mean that in vitro IgG1 anti-D mediates red cell destruction mainly by phagocytosis, while IgG3 anti-D causes their destruction predominantly by prolonged cytolysis. These differences between the effector functions of human monoclonal IgG1 and IgG3 anti-D antibodies might have important implications for their use in the prophylaxis of haemolytic disease of the new-born.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3192267      PMCID: PMC1384907     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  SPLENIC DESTRUCTION OF RH-SENSITIZED, AND OF HEATED RED CELLS.

Authors:  P CROME; P L MOLLISON
Journal:  Br J Haematol       Date:  1964-04       Impact factor: 6.998

2.  Haemolytic activity of human blood monocytes. Lysis of human erythrocytes treated with anti-A serum.

Authors:  G Holm; S Hammarström
Journal:  Clin Exp Immunol       Date:  1973-01       Impact factor: 4.330

3.  Fc receptors for IgG1 and IgG3 on human mononuclear cells--an evaluation with known levels of erythrocyte-bound IgG.

Authors:  B Zupańska; E E Thomson; A H Merry
Journal:  Vox Sang       Date:  1986       Impact factor: 2.144

4.  Phagocytosis requires repeated triggering of macrophage phagocytic receptors during particle ingestion.

Authors:  D R Shaw; F M Griffin
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

5.  Exocytosis and macrophage-mediated antibody-dependent cellular cytotoxicity: a cautionary note.

Authors:  R H Beelen; W S Walker
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

6.  Mechanisms of red cell destruction mediated by non-complement binding IgG antibodies: the essential role in vivo of the Fc part of IgG.

Authors:  A E von dem Borne; D Beckers; C P Engelfriet
Journal:  Br J Haematol       Date:  1977-08       Impact factor: 6.998

7.  A simple quantitative method to assess the in vitro engulfing and degradative potentials of mouse peritoneal phagocytic cells.

Authors:  T Morita; E H Perkins
Journal:  J Reticuloendothel Soc       Date:  1965-12

8.  Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma.

Authors:  J B Margolick; J L Ambrus; D J Volkman; A S Fauci
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

9.  Human monocytes and U937 cells bear two distinct Fc receptors for IgG.

Authors:  R J Looney; G N Abraham; C L Anderson
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

10.  Some quantitative aspects of the human monocyte erythrophagocytosis and rosette assays.

Authors:  R Douglas; N V Rowthorne; J V Schneider
Journal:  Transfusion       Date:  1985 Nov-Dec       Impact factor: 3.157

View more
  6 in total

1.  Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis.

Authors:  E I Rigopoulou; E T Davies; A Pares; K Zachou; C Liaskos; D-P Bogdanos; J Rodes; G N Dalekos; D Vergani
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

2.  Human monoclonal antibodies to C, c, E, e and G antigens of the Rh system.

Authors:  K Thompson; G Barden; J Sutherland; I Beldon; M Melamed
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

3.  Synergistic effect of blending IgG1 and IgG3 monoclonal anti-D in promoting the metabolic response of monocytes to sensitized red cells.

Authors:  A G Hadley; B M Kumpel
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

4.  Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteers.

Authors:  J Goodrick; B Kumpel; D Pamphilon; I Fraser; G Chapman; B Dawes; D Anstee
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

5.  Antibody-mediated immunosuppression can result from RBC antigen loss independent of Fcγ receptors in mice.

Authors:  Amanda Mener; Seema R Patel; Connie M Arthur; Sean R Stowell
Journal:  Transfusion       Date:  2018-11-26       Impact factor: 3.157

6.  Functions of Antibodies.

Authors:  Donald N Forthal
Journal:  Microbiol Spectr       Date:  2014-08-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.